Daewoong pharmaceutical Co.,Ltd

KRX:069620.KS

142100 (KRW) • At close September 13, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) KRW.

202320222021202020192018201720162015201420132012201120102009200820072006
Operating Activities:
Net Income 121,738.68339,163.16930,257.00324,148.06628,865.606-15,417.24535,436.33726,125.87135,673.70230,469.95657,974.40133,512.86450,728.10517,562.8349,467.00832,725.33658,826.03148,523.054
Depreciation & Amortization 42,700.67739,694.66440,883.44140,881.70740,195.36751,300.47740,114.82327,813.79723,099.05917,573.1618,176.70917,954.36816,128.710,184.24213,589.89811,955.98911,459.1459,932.299
Deferred Income Tax -72,753.2510-7,186.04-383.339-8,931.94943,056.9349,849.354-11,195.78520,235.203000000000
Stock Based Compensation 252.7161,840.6222,004.5531,194.517943.213633.05329.345193.59988.893000000000
Change In Working Capital -25,719.91331,582.837-29,851.56327,954.27-14,903.588-39,493.59112,278.416-29,598.972-43,363.581-22,942.222-46,593.621-16,528.3068,621.265-13,533.0478,216.81-33,184.902-51,557.292-17,909.882
Accounts Receivables -3,696.345-24,400.371-27,914.12453,918.957-22,120.084-11,982.443-27,648.541-21,171.295-12,723.606000000000
Inventory -36,581.61340,557.64558.18505,404.229-11,273.321-23,691.29-23,056.518-16,753.4391,202.833-31,803.065-3,842.515-6,921.877227.646-10,143.829-9,315.45-31,024.389-11,988.377
Accounts Payables 16,597.16412,407.73-8,373.1031,865.32412,600.1312,513.22818,848.35915,816.7184,339.749000000000
Other Working Capital -2,039.1193,017.8336,377.479-27,830.011-10,787.864-28,220.2735,969.706-6,542.454-26,610.142-24,145.055-14,790.556-12,685.7915,543.142-13,760.6930-23,869.452-20,532.903-5,921.505
Other Non Cash Items 64,789.8995,933.3113,886.8857,186.03611,431.6277,419.9356,229.8982,038.861154.56844.31924,599.56210,084.9043,344.8115,896.473-2,599.01319,829.8257,082.1378,417.489
Operating Cash Flow 131,008.811118,214.60339,994.279100,981.25757,600.27647,499.563103,938.17315,377.37135,887.83625,945.21354,157.05145,023.8378,822.88120,110.49893,907.85531,326.24825,810.02148,962.96
Investing Activities:
Investments In Property Plant And Equipment -156,172.156-113,308.833-74,794.323-59,696.31-50,106.758-57,061.685-96,755.474-163,251.851-98,308.697-48,956.039-19,093.297-31,877.122-45,058.687-29,253.35-19,968.868-43,444.939-37,031.047-14,197.897
Acquisitions Net -4,286.924-8,966.361-572.21-1,000-1,125.97-6,600-26,900.135-20,625.607-39,580.572-2,746.648-6,640.2074,428.242-7,342.456-673-430-5,529.034-1,114.136-672.461
Purchases Of Investments -18,850.374-23,592.102-319,005.356-448,726.897-225,852.897-234,000.83-112,790.38-95,669.282-60,218.791-119,142.567-38,711.692-518.404-9,705.675-3,455.21-121,651.144-15,595.75-24,329.524-25,012.281
Sales Maturities Of Investments 13,153.91130,574.747306,358362,142.411189,844.833223,101.436135,562.549104,726.06287,923.93238,368.82911211,031.37639,940.96668,652.49150,446.4235,122.8123,984.50315,380.914
Other Investing Activites 534.9928,420.828330.51920,129.1311,635.6745,941.58627,878.819,052.4371,589.7233,030.695832.4633,977.2494,122.71-4,760.1922,907.335-12,623.182-6,174.611-2,263.557
Investing Cash Flow -165,620.55-106,871.719-87,683.369-127,151.665-85,605.118-68,619.493-73,004.641-155,768.241-108,594.405-129,445.73-63,500.734-12,958.659-18,043.14230,510.741-67,451.275-72,070.095-44,664.815-26,765.282
Financing Activities:
Debt Repayment -1,148.9-201,211.94-143,258.42-94,357.295-202,564.761-93,390.172-105,470.599-44,980.879-20,151.473-500.095-6,947.549-31,940.619-56,9450-33,000-55,788.938-20,0000
Common Stock Issued 49,889.893040,249.14729,987.3130000001,362.36202,145.2080001,9490
Common Stock Repurchased -2,244.7160140,951.29141,945.43300000040,187.980-3,467.202-6,009.477-2,993.889-13,060.50-5,512.426
Dividends Paid -7,277.847-6,641.525-6,457.617-6,192.521-6,192.522-6,192.522-6,192.522-7,224.609-7,224.609-8,256.696-8,016.21-7,782.714-5,716.021-7,500.51-6,870.717-7,298.179-7,298.179-6,494.974
Other Financing Activities -0224,794.26618,739.532-4,795.813203,097.12894,804.84394,976.789211,357.03595,236.218108,267.45803,056.70314.818-0.0010124,065.68328,162.1510
Financing Cash Flow 39,218.4315,516.59750,223.93266,587.117-5,660.155-4,777.851-16,686.332159,151.54867,860.13699,510.66726,586.583-36,666.629-63,968.197-13,509.988-24,864.60647,918.0662,812.972-12,007.4
Other Information:
Effect Of Forex Changes On Cash -291.649184.4731,073.215-211.654425.497110.172-1,406.341-599.081638.403-20.427-141.6550000000.001
Net Change In Cash 8,554.92827,043.9543,608.05740,205.056-33,239.501-25,787.60812,840.85918,344.613-3,713.021-4,010.27717,101.245-4,601.459-3,188.45937,111.2511,591.9757,174.219-16,041.82210,190.279
Cash At End Of Period 111,506.188102,951.2675,907.30672,299.2532,094.19465,333.69591,121.30378,280.44459,935.83263,648.85267,659.12950,557.88455,159.34374,250.80237,139.55135,589.90228,415.68339,605.206